Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.64
0.226.43%
Last update: Oct 15, 5:48 PM
$3.65
0.236.72%
Immuneering Corp (IMRX) Stock Price, Quote, News & History
IMRXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Immuneering (NASDAQ:IMRX) through any online brokerage.
Other companies in Immuneering’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Immuneering has a consensus price target of $15.13.
The stock price for Immuneering (NASDAQ: IMRX) is $3.6497 last updated October 15, 2026 at 5:48 PM EDT.
There are no upcoming dividends for Immuneering.
Immuneering does not have any upcoming earnings scheduled.
There is no upcoming split for Immuneering.
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
